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Introduction
The ubiquitin (Ub)-related protein SUMO functions by
becoming covalently attached to other proteins as a post-
translational modification, and SUMO conjugation is essential
for viability of Saccharomyces cerevisiae and of most other
eukaryotic cells (Gill, 2004; Hay, 2005; Johnson, 2004; Muller
et al., 2004). Proteomic approaches have identified 300-400
proteins in S. cerevisiae that are sumoylated, which suggests
that 5-10% of all yeast proteins are modified by SUMO to some
extent (Denison et al., 2004; Hannich et al., 2005; Panse et al.,
2004; Wohlschlegel et al., 2004; Wykoff and O’Shea, 2005;
Zhou et al., 2004). However, the essential function is unknown.
Like Ub, SUMO is attached to lysine residues in substrates
through an amide bond between the C terminus of SUMO
and the -amino group of the lysine residue. SUMO
conjugation is carried out by a three-step enzyme pathway,
analogous to the Ub pathway, that consists of a heterodimeric
activating enzyme (E1), a single conjugating enzyme (E2)
called Ubc9, and a growing collection of SUMO ligases (E3s)
(Gill, 2004; Johnson, 2004; Muller et al., 2004). In the Ub
pathway, E3s are the primary substrate specificity factors
(Hershko and Ciechanover, 1998; Pickart and Eddins, 2004),
but it remains to be determined whether SUMO E3s act
similarly. Unlike E2s for Ub, Ubc9 binds directly to the
KXE consensus site for SUMO attachment (where  is a
large hydrophobic residue and K is the modified lysine), and
in vitro Ubc9 can promote site-specific sumoylation of many
physiological targets in the absence of an E3. However, in
vivo the vast majority of sumoylation is E3-dependent, at
least in yeast.
S. cerevisiae contains members of two of the four known
families of SUMO E3s, including two Siz/PIAS (protein
inhibitor of activated STAT) proteins, called Siz1 and
Siz2/Nfi1, as well as a distinct E3 called Mms21 (Johnson
and Gupta, 2001; Takahashi et al., 2001a; Zhao and Blobel,
2005). Deletion of SIZ1 and SIZ2 results in loss of >90%
of all SUMO conjugates, indicating that most SUMO
conjugation in yeast is Siz dependent. MMS21 is an essential
gene, but mms21 mutants in which the SUMO ligase activity
has been inactivated are viable (Zhao and Blobel, 2005).
Siz/PIAS E3s are found in all eukaryotes and share a
conserved ~400 amino acid N-terminal region that contains
several distinct domains. One of these is the SP-RING
(Siz/PIAS-RING), which is related to the RING Zn2+-binding
domains present in many E3s for Ub and which is required
for the sumoylation reaction (Sachdev et al., 2001; Takahashi
et al., 2001a). Immediately N-terminal to the SP-RING is a
conserved region called the ‘PINIT’ domain that has also
been implicated in the sumoylation reaction (Takahashi and
Kikuchi, 2005). Near their N termini, Siz/PIAS proteins
contain a sequence called a SAP (scaffold attachment factor,
acinus, PIAS) domain. SAP domains, including those from
PIAS proteins, bind DNA (Okubo et al., 2004; Tan et al.,
2002). Siz/PIAS proteins also contain unique C-terminal
domains, which share little sequence similarity with each
other or with other proteins. The functions of the various parts
Saccharomyces cerevisiae contains two Siz/PIAS SUMO E3
ligases, Siz1 and Siz2/Nfi1, and one other known ligase,
Mms21. Although ubiquitin ligases are highly substrate-
specific, the degree to which SUMO ligases target distinct
sets of substrates is unknown. Here we show that although
Siz1 and Siz2 each have unique substrates in vivo,
sumoylation of many substrates can be stimulated by either
protein. Furthermore, in the absence of both Siz proteins,
many of the same substrates are still sumoylated at low
levels. Some of this residual sumoylation depends on
MMS21. Siz1 targets its unique substrates through at least
two distinct domains. Sumoylation of PCNA (proliferating
cell nuclear antigen) and the splicing factor Prp45 requires
part of the N-terminal region of Siz1, the ‘PINIT’ domain,
whereas sumoylation of the bud neck-associated septin
proteins Cdc3, Cdc11 and Shs1/Sep7 requires the C-
terminal domain of Siz1, which is also sufficient for cell
cycle-dependent localization of Siz1 to the bud neck.
Remarkably, the non-sumoylated septins Cdc10 and Cdc12
also undergo Siz1-dependent sumoylation if they are fused
to the short KXE SUMO attachment-site sequence.
Collectively, these results suggest that local concentration
of the E3, rather than a single direct interaction with the
substrate polypeptide, is the major factor in substrate
selectivity by Siz proteins.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/119/22/4749/DC1
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of Siz/PIAS proteins have only been partially characterized,
and it is not known how Siz/PIAS proteins interact with their
substrates.
In fact, it is not clear to what extent each SUMO E3 has
distinct substrates. SIZ1 is required for sumoylation of the bud
neck-associated septin proteins Cdc3, Cdc11 and Shs1/Sep7 and
of the PCNA (proliferating  cell nuclear antigen) ortholog Pol30
at its major sumoylation site, whereas SIZ2 is required for
sumoylation of several small proteins that have not been
identified (Hoege et al., 2002; Johnson and Gupta, 2001;
Takahashi et al., 2001b). By contrast, either Siz1 or Siz2 can
stimulate sumoylation of Flp or Top2 (Chen et al., 2005;
Takahashi et al., 2005). It is not known which of these situations
is more common. This issue has been complicated by the
apparent promiscuity of Siz/PIAS-dependent sumoylation in
vitro. For example, SIZ1 is absolutely required for septin
sumoylation in vivo, but in vitro Siz1 and Siz2 stimulate septin
sumoylation at comparable rates (Takahashi et al., 2003),
suggesting that in vitro experiments do not necessarily reproduce
in vivo substrate specificity. Genetic data suggest that SIZ1 and
SIZ2 have some overlapping functions. One such function
involves controlling the copy number of the endogenous yeast
plasmid the 2 micron circle (2 m) (Chen et al., 2005). High
copy number of 2 m is responsible for many of the conspicuous
growth defects of the siz1 siz2 double mutant. Knockout mice
have been made for three of the four mouse PIAS genes, but no
defect in SUMO conjugation has been detected in the single
mutants, consistent with the possibility that PIAS proteins also
have overlapping functions (Liu et al., 2004; Roth et al., 2004;
Santti et al., 2005; Wong et al., 2004).
Sumoylation of both septins and PCNA shows striking cell
cycle dependence, with PCNA being modified during S phase,
whereas septins are modified during mitosis (Hoege et al.,
2002; Johnson and Blobel, 1999). PCNA is also heavily
sumoylated upon treatment of cells with high levels of the
DNA-damaging agent methyl methane sulfonate (MMS), but
MMS does not induce sumoylation of septins. This distinct
regulation is particularly striking given the fact that both
septins and the major sumoylation site of PCNA absolutely
require Siz1 for their sumoylation. Thus, Siz1 functions as part
of two separately regulated sumoylation systems.
Here we address two questions related to how substrates are
selected for sumoylation. One is whether different SUMO E3s
target distinct sets of substrates, similar to E3s in the Ub
pathway, or whether they generally target overlapping sets of
substrates. The second question focuses on what features of
Siz1 are responsible for selecting Siz1-dependent substrates,
such as septins and PCNA, for sumoylation. 
Results
More than one E3 stimulates sumoylation of many
SUMO substrates
It is difficult to determine from anti-SUMO immunoblots of
whole cell lysates, which contain thousands of bands, whether
most substrates are targeted specifically by one or the other Siz
protein. It is also not known whether deleting both SIZ genes
completely eliminates sumoylation of the proteins that undergo
Siz-stimulated sumoylation. To answer these questions, we
surveyed a number of SUMO substrates for Siz dependence. C-
terminal His8- and HA-epitope tags were fused to substrate
genes at their chromosomal loci, generating strains that
Journal of Cell Science 119 (22)
expressed native levels of tagged proteins. These strains had no
growth defects, demonstrating that the tagged proteins are at
least partially functional (not shown). Tagged proteins
were isolated by Ni2+ chromatography and analyzed by
immunoblotting with antibodies  against either HA or SUMO
(Fig. 1). This experiment identified one new protein, the splicing
factor Prp45, whose sumoylation is stimulated only by SIZ1.
However, sumoylation of most substrates could be stimulated by
either SIZ1 or SIZ2. For some proteins, such as Top2 (Fig. 1)
and Flp1 (Chen et al., 2005), sumoylation took place at
approximately wild-type levels in both the siz1 and siz2 single
mutants. Sumoylation of other substrates, including Spt7, Abf1,
Rsc2, Gcn5, Ysh1 and Top1 occurred at near wild-type levels in
the siz2 mutant, but was reduced approx. two to fivefold in the
siz1 mutant. Sumoylation of all substrates shown in Fig. 1 was
dramatically reduced in the double mutant, although several
substrates, most notably Top1, but also Rsc2, Gcn5 and Top2,
were still detectably sumoylated (Fig. 1). These experiments
showed that sumoylation of many substrates can be stimulated
by either Siz protein and that many Siz substrates are still
sumoylated, albeit at dramatically reduced levels, in the absence
of both SIZ1 and SIZ2.
Mms21, the recently  identified third S. cerevisiae SUMO
E3, was an obvious candidate to contribute to Siz-independent
Fig. 1. Both Siz1 and Siz2 stimulate sumoylation of many proteins.
Lysates from cells in which the indicated proteins had been tagged
with the HA epitope and a His8 tag were subjected to denaturing Ni-
NTA affinity chromatography. Eluates were analyzed by SDS-PAGE
and immunoblotting with antibodies against HA (lower panels) or
Smt3 (top panels). SIZ genotypes are indicated over the lanes. Bands
corresponding to unmodified proteins are indicated with arrowheads.
Open brackets indicate sumoylated species. For Spt7, Abf1, Rsc2
and Gcn5, sumoylated species were detected with the HA Ab on a
short exposure and are shown. Other substrates required long
exposures of the HA blot to detect sumoylated species (not shown).
A cross-reacting band is designated with an asterisk.
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4751Siz substrate selection determinants
sumoylation. We wanted to determine whether Siz proteins and
Mms21 function redundantly, by examining sumoylation in
strains that both lack SIZ genes and contain mutations that
eliminate the sumoylating activity of MMS21. However, Zhao
and Blobel reported that mms21 siz1 and mms21 siz2 double
mutants, as well as the siz1 siz2 mms21 triple mutant, are all
inviable (Zhao and Blobel, 2005). Because the inviability of
these mutants might have involved hyper-amplification of 2
m, which causes severe growth defects, we repeated this
experiment in a cir° strain, which lacks 2 m. We also used a
different allele of mms21. Instead of a C-terminal truncation
mutant, we used a mutant that contained two point mutations
in the SP-RING of Mms21 (mms21-sp), which eliminates the
sumoylation stimulating activity of the S. pombe ortholog of
MMS21 (Andrews et al., 2005). In our experiment, both double
mutants siz1 mms21-sp and siz2 mms21-sp were viable,
although they grew more slowly (doubling time of 2.7 and 2.5
hours, respectively) than either the siz1 siz2 double mutant (1.8
hours) or the mms21-sp single mutant (2.0 hours; Fig. 2A). The
siz1 siz2 mms21-sp triple mutant was dead in our experiment
(not shown), as found by Zhao and Blobel (Zhao and Blobel,
2005). These results indicate that SIZ1, SIZ2 and MMS21 are
each capable of carrying out a shared function that is required
for yeast viability. It is most likely that the relevant difference
between our results and those in Zhao and Blobel is the absence
of 2 m, but we have not ruled out the possibility that the
mms21 allele or a difference in the strain background is
involved. Partial functional redundancy of Siz proteins and
Mms21 was also supported by the observation that
sumoylation of the nucleolar protein Net1 was more strongly
reduced in the siz1 siz2 and mms21-sp siz1 double mutants than
in any of the three single mutants (Fig. 2B). Thus, SIZ1, SIZ2,
and MMS21 can all promote sumoylation of certain shared
substrates.
Different domains in Siz1 are required for sumoylation of
different proteins
Siz1 and Siz2 are large proteins with several conserved
domains. To determine which domains are required for
targeting various substrates for sumoylation, we constructed
chimeras between Siz1 and Siz2, as well as versions of Siz1
containing short deletions. These Siz constructs were
expressed at similar levels to wild-type Siz1 except for
construct 4 (Fig. 3A), which was present in at least 20-fold
higher levels (Fig. 3B). This probably results from the presence
of the C-terminal domain of Siz1, which targets Siz1 for
proteolysis (Takahashi and Kikuchi, 2005), in all constructs
except this one. Further evidence for the correct folding and
activity of these Siz variants was provided by the fact that they
all promoted wild-type levels of SUMO conjugation to at least
one substrate (see below).
Plasmids expressing these Siz variants were introduced into
siz1 siz2 strains containing tagged versions of substrate
proteins, and sumoylation of these substrates was examined.
Several conclusions can be drawn from these experiments. One
is that the C-terminal domain, which is divergent between Siz1
and Siz2, is necessary and sufficient for the Siz1-specificity of
septin sumoylation. The septin Cdc3 was sumoylated
efficiently by construct 3, which contained the C terminus of
Siz1 together with the N-terminal region from Siz2, but not by
construct 4, which contained part of the N terminus of Siz1 and
the C-terminal region from Siz2 (Fig. 3D). Consistent with a
role for the non-conserved C-terminal domains of Siz/PIAS
proteins in substrate specificity, the C-terminal domain of Siz2
was required for formation of three uncharacterized SIZ2-
dependent SUMO conjugates detected between 40 and 55 kDa
on anti-SUMO immunoblots of whole cell lysates (Fig. 3C).
Thus, the C-terminal domains of both Siz1 and Siz2 confer
specificity for certain substrates.
However, the C-terminal domains are not responsible for all
differences in substrate specificity between Siz1 and Siz2.
Remarkably, the Siz1-dependence of SUMO attachment to
PCNA (Pol30) and Prp45 involved sequences in the N-terminal
region of Siz1 (Fig. 3D). Sumoylation of these proteins was
not stimulated by construct 3, which promoted septin
sumoylation, but instead was promoted by construct 4, which
contained only the N-terminal 309 amino acids of Siz1.
The SAP domain of Siz1 was also required for sumoylation
of PCNA and for the Siz-dependent fraction of SUMO
attachment to most other proteins tested, also required the SAP
domain of Siz1. Deleting the SAP domain had no effect on
sumoylation of septins, and only slightly reduced sumoylation
of Prp45, indicating that the SAP domain is not essential for
the ability of Siz1 to stimulate sumoylation. The requirement
for the SAP domain could indicate that DNA binding or a
protein interaction involving the SAP domain is required for
Siz proteins to stimulate SUMO attachment to certain proteins.
However, the SAP effect might result, at least partially, from
the dramatically reduced nuclear localization of this mutant,
which can be detected with Siz1-SAP-GFP fusions
(Takahashi and Kikuchi, 2005) (data not shown). Siz1
normally localizes primarily to the nucleus throughout the cell
Fig. 2. Siz proteins and Mms21 have overlapping functions.
(A) Strains of the indicated genotypes were incubated on a YPD
plate for 2 days at 30°C. Doubling times of mutants are indicated in
parentheses. (B) Yeast strains of the indicated genotypes containing
Net-His8 HA were analyzed as in Fig. 1, with immunoblotting with
anti-Smt3 (top panel) or anti-HA (bottom panel). Designations are as
in Fig. 1.
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cycle (Johnson and Gupta, 2001; Takahashi et al., 2001b). This
effect could result from a role for the SAP domain in either
nuclear import or nuclear retention (see Discussion). All
substrates tested other than the septins localize to the nucleus
and would be expected to be sumoylated in the nucleus.
Fig. 3 showed that the determinants required for Siz1-
dependent sumoylation of PCNA and Prp45 are in the N-
terminal region of Siz1. To analyze this region further, two
additional chimeras were made containing either the N-
terminal or C-terminal half of this region. This experiment
showed that amino acids 180-309 of Siz1 were sufficient to
account for the differential substrate specificity between Siz1
and Siz2 for PCNA and Prp45 (Fig. 4B). This sequence is part
of the PINIT domain and is quite well conserved between Siz1
and Siz2, with 41% sequence identity and 63% similarity. This
similarity suggested that further characterization of this
sequence was unlikely to identify an entire domain that would
be sufficient for targeting Siz1 to PCNA and Prp45, but rather
would probably identify a fairly small sequence difference that
prevents Siz2 from promoting sumoylation of these proteins.
This experiment (Fig. 4B) was done using cells treated with
0.2% MMS, and the chimera supported an equal level of PCNA
sumoylation as full-length Siz1, indicating that the mechanism
for induction of PCNA sumoylation upon DNA damage is
intact when only these 130 amino acids of Siz1 are present. We
also tested whether this chimera still promoted correct cell-
cycle-dependent sumoylation of PCNA by doing alpha factor
release experiments. (Fig. 4C). In both the wild-type and
chimera samples, PCNA sumoylation peaked 30 min after
release from alpha factor block, consistent with previous
results in wild-type cells (Hoege et al., 2002). This result
demonstrated that no Siz1 sequences outside amino acids 180-
309 of Siz1 are required for cell-cycle regulation of PCNA
sumoylation.
We also further characterized the C-terminal domain of Siz1.
This sequence has been shown previously to be required for
localization of a portion of Siz1 to the bud neck (Takahashi
et al., 2003), and we also found that only those chimeras
containing it localized to the bud neck (data not shown). To
identify the sequences involved, segments of this domain were
fused to GFP and tested for bud neck localization (Fig. 5B). At
least two sections of this C-terminal domain localized to the
bud neck independently: one containing the extreme C
terminus of the protein (residues 836-904), and the other a
larger region upstream of this (residues 556-836). Deleting
from amino acid 836 in either direction resulted in a gradual
reduction of bud neck localization, supporting a model where
multiple sequences within the C-terminal domain contribute
additively to its ability to bind the bud neck. The C-terminal
domain, starting from residue 556, contains very high
Journal of Cell Science 119 (22)
Fig. 3. Different domains in Siz1
participate in sumoylation of different
substrates. (A) Diagram of the Siz variants
used in experiments in B-D. Portions
corresponding to Siz2 sequence are shaded
grey. All variants also include a C-terminal
HA epitope tag. (B) Lysates from siz1 siz2
cells expressing the indicated HA-tagged
Siz variants were analyzed by SDS-PAGE
and immunoblotting with an antibody
against the HA epitope. The band
corresponding to Siz1-HA, as well as
constructs 3 and 5 is indicated with an
arrowhead. Open arrows indicate two bands
corresponding to construct 4 [the upper
band is sumoylated (data not shown)].
Asterisks designate bands that cross-react
with the Ab. (C) (Left) Lysates from siz1
siz2 cells that lacked the major sumoylation
sites in all three septins (EJY411) and
contained the indicated constructs were
analyzed by SDS-PAGE and
immunoblotting with an Ab against Smt3.
(Right) Lysates from siz1 or siz2 strains
that lacked the major septin sumoylation
sites were analyzed by immunoblotting
with an Ab against Smt3. Dots between
panels indicate position ofSIZ2-dependent
SUMO conjugates. (D) siz1 siz2 cells
contained Siz variants as indicated over the
lanes and tagged substrates as indicated
below each pair of panels. Cdc3 and Pol30 were tagged with only HA and were analyzed by subjecting whole cell lysates to SDS-PAGE and
immunoblotting with an Ab against HA. The Cdc3-HA cultures were arrested with nocodazole, and the Pol30-HA cultures were treated for 2
hours with 0.2 % MMS. The sumoylated form of Pol30 indicated is the mono-sumoylated Lys164 conjugate. Other substrates bore HA  and
His8 tags and were analyzed by denaturing Ni-NTA affinity chromatography followed by SDS-PAGE and immunoblotting with antibodies
against HA (lower panels) or Smt3 (top panels). Designations are as in Fig. 1. The white asterisk in lane 4 of the Cdc3 panel indicates the band
corresponding to the construct 4 fusion protein, which is visible in this experiment because a whole cell lysate was analyzed.
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proportions of Ser/Thr (25%), Pro (11%) and Asn (11%)
residues, but there are no obvious repeated motifs that could
account for these observations.
Fig. 5B shows nocodazole-arrested cells, but similar
experiments with log phase cells showed that bud neck
localization of these truncations occurred only during mitosis,
with the same timing as full-length Siz1 (not shown). This
result demonstrated that the cell cycle-dependent localization
is retained by these truncations. We also tested whether the C
terminus of Siz1 contains all sequences necessary for the cell-
cycle-dependent sumoylation of septins by doing alpha factor
release experiments (Fig. 5D). This experiment showed that the
Siz2(1-417)-Siz1(441-904) fusion (construct 3 in Fig. 3)
supported wild-type cell-cycle-dependent Cdc3 sumoylation.
Thus, no Siz1-specific sequences outside the C terminus are
required for cell cycle regulation of septin sumoylation.
Adding sumoylation consensus sequences to Cdc10
and Cdc12 allows Siz1-dependent sumoylation
The above results led us to ask whether co-localization of Siz1
and the substrate may be the primary factor in preferential
stimulation of SUMO attachment to certain substrates by Siz
proteins. To address this question we tested whether the septins
Cdc10 and Cdc12, which are present in septin complexes at the
bud neck but which are not normally sumoylated at high levels,
would be sumoylated if the SUMO attachment site sequence
KXE were added to them. This was done by adding the
tetrapeptide LKEE to the C terminus of Cdc10 and the
dipeptide EE to the C terminus of Cdc12, generating the
sequence LKEE. These sequences should introduce binding
sites for Ubc9, but would not be expected to create specific
binding sites for Siz1. Both fusions also contained His6 and
HA-epitope tags C-terminal to the sumoylation site. These
fusions, Cdc10-S and Cdc12-S, both now underwent Siz1-
dependent sumoylation, which, like sumoylation of Cdc3,
Cdc11 and Shs1, was stimulated by G2/M arrest with
nocodazole and required the C terminus of Siz1 (Fig. 6).
Whereas Cdc12 was sumoylated at a relatively low level,
Cdc10 was sumoylated robustly, to a level comparable to that
of Cdc11 (Fig. 6B, lower panel, lane 3). We do not know why
introduction of one sumoylation site in Cdc10 resulted in
formation of two sumoylated species of Cdc10, one of which
reacted poorly with the anti-HA antibody (Fig. 6A). These
results suggest that the same Siz1-bud neck interactions that
occur in wild-type cells allow Siz1 to stimulate SUMO
attachment to suitable lysine residues in neighboring proteins.
Discussion
We found that there are four classes of Siz-dependent SUMO
substrates: those that require Siz1 (such as PCNA, Prp45 and
septins), those that require Siz2 (several unidentified
conjugates), those whose sumoylation can be promoted by
either Siz1 or Siz2 (many substrates), and those that can be
sumoylated with the assistance of any of Siz1, Siz2 or Mms21
(Net1). Two extreme models could explain how SUMO E3s
stimulate sumoylation of overlapping sets of substrates. One is
that different E3s specifically interact with the same substrates.
In the ubiquitin system different E3s sometimes target the same
substrates, but often under different conditions (Hershko and
Ciechanover, 1998; Muratani et al., 2005). A second model is
that SUMO E3s may not interact directly with the substrate at
all, but merely stimulate SUMO attachment to lysine residues
that are selected by Ubc9. Although this model contrasts with
what is known about ubiquitin E3s, Ubc9 is clearly different
from Ub E2s in its ability to bind directly to the attachment
site peptide (Bernier-Villamor et al., 2002).
Our results are most consistent with an intermediate model,
Fig. 4. Siz1 specificity for Pol30 and Prp45 involves part of the
conserved PINIT domain. (A) Diagram of Siz variants used in B and
C. Portions corresponding to Siz2 sequence are in grey. (B) Lysates
prepared from siz1 cells containing the indicated Siz variants and
either Pol30-HA or Prp45-HA-His8 were either analyzed directly
(Pol30) or subjected to Ni-NTA affinity chromatography (Prp45),
followed by SDS-PAGE and immunoblotting with an Ab against HA.
Pol30-HA cultures were treated with 0.2% MMS. Designations are
as in Fig. 1. A bracket indicates the three SUMO-Pol30 bands (the
middle one is monosumoylated at Lys127, which is not Siz1
dependent). Open arrows indicate the bands corresponding to the
HA-tagged Siz1-Siz2 fusions in lanes 3 and 4 of the Pol30 blot. Full-
length Siz1 is not visible here. All lanes of the Pol30 panel were
from the same exposure of the same blot, but lanes 3 and 4 were
spliced to remove irrelevant lanes. (C) siz1 Pol30-HA cells
containing the indicated Siz variants were arrested with alpha factor
and released into fresh medium. Whole cell lysates made from
samples taken at the indicated timepoints were analyzed as in B.
Bands corresponding to unmodified Pol30 and the Lys164-linked
SUMO conjugate are indicated.
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in which the likelihood of a Siz E3 stimulating SUMO
attachment to a particular substrate is determined by the local
concentration of the E3. This could be affected by several
factors including overall subcellular localization of the E3 and
substrate, interactions between the E3 and features of the
substrate’s environment, and direct E3-substrate interactions.
This model would explain the continuum of substrate
specificities that is observed among SUMO E3s. Sumoylation
of substrates would be strongly stimulated by E3s that interact
with nearby features, but might also be enhanced at some level
by other E3s present at lower concentrations. This would also
explain how Cdc10 and Cdc12 could be converted into Siz1-
dependent SUMO substrates merely by adding two or four
amino acids to generate the sumoylation consensus sequence:
Siz1 binds to the bud neck, resulting in a high local
concentration in the vicinity of the introduced consensus
sequences. We are not implying that Siz1 may not interact
directly with Cdc10 and/or Cdc12, only that any Siz1
interactions that occur with Cdc10-S and Cdc12-S probably
occur equally with wild-type Cdc10 and Cdc12. In wild-type
cells, Siz1 interactions with Cdc10 or Cdc12 may stabilize the
Siz1-bud neck interaction, thereby promoting SUMO
conjugation to the other septins. This model is also consistent
with the observation that a non-sumoylated protein can be
targeted for sumoylation merely by adding a sumoylation
consensus sequence and a nuclear localization sequence
(Rodriguez et al., 2001). The E3-dependence of this
phenomenon is unknown, but the known E3s are concentrated
either in the nucleus or at the nuclear pore complex.
This model would also explain the results where Siz/PIAS
E3s appear to show only modest substrate specificity in vitro,
where the E3s are present at relatively high concentrations. In
cells, Siz1 has been reported to be present at only ~150
molecules/cell (Ghaemmaghami et al., 2003). This model
might also account for the observation that often many subunits
of a particular multisubunit complex are modified by SUMO
(Denison et al., 2004; Hannich et al., 2005; Panse et al., 2004;
Sterner et al., 2006; Wohlschlegel et al., 2004). Binding of a
Siz protein to a complex might target multiple subunits for
sumoylation simultaneously. Consistent with this possibility,
both the septins and the SAGA subunits Spt7 and Gcn5 showed
similar patterns of E3 dependency (Figs 1, 6) (Johnson and
Blobel, 1999). The biological significance of such a mode of
substrate selection is unclear, but it is conceivable that in some
situations attaching SUMO to any of several different lysine
residue in a particular locale may be sufficient for SUMO’s
function. The ability of SUMO to be attached to multiple
subunits of various multiprotein complexes raises the
disheartening possibility that SUMO attachment to these
subunits may be functionally redundant.
Journal of Cell Science 119 (22)
Fig. 5. The C-terminal domain of Siz1 is sufficient for cell-cycle-dependent binding to the bud neck. (A) Diagram of GFP fusions containing
parts of the C-terminal domain of Siz1. Ability to localize to the bud neck is indicated. (B) Fluorescence microscopy of nocodazole-arrested
siz1 cells containing GFP fusions as illustrated in A. Bar, 5 m. (C) Lysates of siz1 cells containing GFP fusions were analyzed by SDS-PAGE
and immunoblotting with an antibody against HA. Note that fusions that fail to localize to the bud neck are present in quantities comparable to
those that do. Lane g was from the same exposure of the same blot, but was spliced to remove extraneous lanes. (D) siz1 Cdc3-HA cells
containing the indicated Siz variants were analyzed as in Fig. 4C. Unmodified Cdc3-HA is indicated, and SUMO-Cdc3 species are indicated by
open square brackets. An asterisk indicates a cross-reacting band.
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Our results do not address the ongoing debate in the
ubiquitin/SUMO field regarding the mechanism of non-HECT
E3s, such as RING and SP-RING E3s, which have been
proposed to act either by ‘allosteric’ activation of the E2-Ubl
(ubiquitin-like protein) thiolester intermediate or as relatively
inert ‘bridging factors’ that bring together the substrate and
thiolester intermediate. The main difference between these
mechanisms involves the functional interaction between the E3
and E2-Ubl thiolester, not the interaction between the E3 and
the substrate. Either mechanism is consistent with a model
where the E3 stimulates sumoylation in the absence of a strong
direct interaction with the substrate, as long as the E3 binds the
E2. The only prediction from these mechanisms regarding
substrate interactions is that if an E3 plays an active role in
stimulating Ubl transfer, it might increase Ubl transfer in vitro
without interacting with the substrate at all. The E3 domain of
the mammalian SUMO E3 RanBP2/Nup358 has this activity
and appears to act by positioning Ubc9 and SUMO in an
optimal orientation for SUMO transfer (Pichler et al., 2004;
Reverter and Lima, 2005). However, RanBP2 is a
stoichiometric subunit of the nuclear pore complex, and it
seems likely that in vivo its subcellular localization has a major
impact on which substrates are targeted for sumoylation.
We show that the C terminus of Siz1 is necessary and
sufficient for bud neck localization, in contrast to published
reports indicating that it is necessary but not sufficient
(Takahashi and Kikuchi, 2005; Takahashi et al., 2003). The
reason for this difference is unclear, but we have generated a
series of GFP fusions, some of them non-overlapping, that all
localize to the bud neck, making it unlikely that our results are
an artifact. It has been suggested that the function of bud neck
localization of Siz1 during mitosis may be to sequester Siz1
away from the nucleus, thereby reducing nuclear sumoylation
(Takahashi and Kikuchi, 2005). Our results suggest that such
competition for Siz1 is not responsible for regulation of PCNA
sumoylation: a chimera that fails to localize to the bud neck
supports the same cell cycle regulation of PCNA sumoylation
as does full-length Siz1 (Fig. 4C). We are not able to conclude
from our results what part of Siz1 is sufficient for the
interactions that result in sumoylation of PCNA and Prp45. We
showed that the relevant difference between Siz1 and Siz2 that
makes sumoylation of these substrates dependent on Siz1 is
residues 180-309 of Siz1. However, in this chimera, Siz2-
derived sequences, such as the SAP domain, could be
contributing to the interaction by functionally substituting for
the corresponding sections of Siz1.
Sumoylation of many substrates depended on the SAP
domain in Siz1, but it remains to be determined whether the
SAP domain has a direct role in substrate selection. SAP
domains bind DNA, and NMR analysis of the PIAS1 SAP
domain identified specific residues that are perturbed by DNA
binding, suggesting that they are contact sites for DNA (Okubo
et al., 2004). The idea that interactions between Siz proteins
and DNA contribute to determining which proteins are
sumoylated is appealing, especially in the case of proteins such
as PCNA, the sumoylation of which during S phase and in
response to DNA damage suggests that a specific DNA-protein
Fig. 6. Addition of a sumoylation consensus sequence converts
Cdc10 and Cdc12 into Siz1 substrates. (A) Lysates from strains
expressing Cdc10-His8-HA (Cdc10), Cdc12-His8-HA (Cdc12), or
versions of these with a sumoylation site consensus sequence
between the C terminus of the protein and the tag (Cdc10-S and
Cdc12-S) were analyzed by denaturing Ni-NTA chromatography,
SDS-PAGE, and immunobloting with antibodies against HA (left
panel) or Smt3 (right panel). Bands corresponding to unmodified and
sumoylated (Su) proteins are indicated. The second SUMO-
containing species in the Cdc10-S sample (right panel) is visible on a
much darker exposure of the HA blot. (B) Whole cell lysates from
strains expressing the indicated forms of Cdc10 and Cdc12 were
analyzed by SDS-PAGE and immunobloting with antibodies against
HA (top panel) or Smt3 (bottom panel). Strains lacked SIZ1 or had
been arrested with nocodazole as indicated. Bands corresponding to
unmodified and sumoylated septins are indicated. Su2-Cdc10
indicates the second sumoylated form of Cdc10, but is not
necessarily a di-sumoylated species. Positions of sumoylated Cdc11
and Cdc3 were determined based on previous results (Johnson and
Blobel, 1999). (C) Whole cell lysates prepared from siz1 cells
expressing Cdc10-S (top panels) or Cdc12-S (bottom panels) and
Siz1 variants shown in Fig. 3A were analyzed by SDS-PAGE and
immunoblotting with an antibody against HA. Lanes are numbered
as in Fig. 3D. Bands corresponding to unmodified and sumoylated
septins are indicated.
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structure might be the target for sumoylation. However, the
failure of Siz1 mutants lacking the SAP domain to localize to
the nucleus complicates interpretation of these results. The
SAP domain could promote either nuclear import or nuclear
retention. If the SAP mutant is not imported into the nucleus,
its inability to sumoylate nuclear proteins is uninformative. Our
attempt to distinguish between these possibilities by examining
Siz1-SAP-GFP localization in the presence of the nuclear
export inhibitor leptomycin B (Neville and Rosbash, 1999) was
inconclusive (not shown). The SAP domain does have two
properties that favor a role in nuclear retention: it does not
contain a classic nuclear localization sequence, and it
apparently binds DNA. Furthermore, Duval and colleagues
found that point mutations in the SAP domain, the PINIT
domain, and the SP-RING of PIAS3L all showed similar
effects on its localization: the mutant proteins localized to both
the nucleus and the cytoplasm, unlike wild-type PIAS3L,
which is strictly nuclear (Duval et al., 2003). The SP-RING
and PINIT mutations both probably eliminate the sumoylation
activity of this protein (Sachdev et al., 2001; Takahashi and
Kikuchi, 2005), suggesting that sumoylation activity toward
certain substrates may be involved in PIAS3L nuclear
retention. We also observed that a Siz1 mutant with an SP-
RING mutation was defective in localizing to the nucleus (not
shown). Thus, it is possible that the inability of Siz1-SAP to
sumoylate certain proteins may be the cause, rather than the
effect, of its failure to localize to the nucleus. Further work will
be required to determine how the SAP domain participates in
sumoylation.
Materials and Methods
Media and genetic techniques
Standard techniques were used (Ausubel et al., 2000). Rich yeast medium,
containing either 2% glucose (YPD) or 2% raffinose (YPR), and synthetic yeast
media (SD) were prepared as described previously (Sherman et al., 1986). galactose
(2%) was used to induce expression from GAL promoters. Cell cycle arrests were
induced by incubating with 10 M -factor (Sigma) or 15 g/ml nocodazole
(Acros, Fisher Scientific).
Plasmids and yeast strain constructions
pRS416-based plasmids expressing Siz1-HA, Siz1-Siz2 chimeras and the Siz1-
SAP mutant contained the SIZ1 promoter starting at nucleotide –477, and a C-
terminal HA tag consisting of the sequence GYPYDVPDYAAFL. Chimera 3 in Fig.
3 contained bp 1-1251 of SIZ2, encoding residues 1-417, and bp 1321-2712 of SIZ1,
encoding residues 441-904. Chimera 4 in Fig. 3 contained bp 1-927 of SIZ1,
encoding residues 1-309, and bp 858-2178 of SIZ2, encoding residues 287-726.
Chimera 3 in Fig. 4 contained bp 1-537 of SIZ1, encoding residues 1-179, and bp
466-2178 of SIZ2, encoding residues 156-726. Chimera 4 in Fig. 4 contained bp 1-
465 of SIZ2, encoding residues 1-155, bp 538-927 of SIZ1, encoding residues 180-
309, and bp 859-2178 of SIZ2, encoding residues 287-726. The Siz1-SAP
construct contains a deletions of bp 139-180 of SIZ1, which encodes residues 47-
60. A larger deletion lacking residues 34-68 had a similar effect. GFP fusion
plasmids (Fig. 5) contained the SIZ1 promoter starting at nucleotide –1457, an N-
terminal enhanced GFP derived from pYX242-GFP (Rosenblum et al., 1998), a C-
terminal HA tag (GYPYDVPDYAAFL) and sections of SIZ1 as follows: (a) bp
1666-2712 (aa 556-904), (b) 2506-2712 (aa 836-904), (c) 2557-2712 (aa 853-904),
(d) 2608-2712 (aa 869-904), (e) 1666-2508 (aa 556-836), (f) 1666-2385 (aa 556-
795) and (g) 2077-2508 (aa 692-836). Construction details are available on request.
Relevant portions of plasmids were sequenced in most cases. Alternatively,
independent plasmid isolates were tested to make sure they had similar effects.
S. cerevisiae strains used are listed in Table S1 in supplementary material. All
strains are derivatives of JD51 (Dohmen et al., 1995). The sequence of the C-
terminal HA tag on Cdc3 and Pol30 was GYPYDVPDYAAFL. The C-terminal HA-
His8 tag on Flp, Top1, Top2, Abf1, Prp45, Rsc2 and Ysh1 was GYPYDVPDYAAF-
LHHHHHHHH, and the His8-HA tag on Spt7, Gcn5, Net1, Cdc10 and Cdc12 was
GHHHHHHHHGYPYDVPDYAAFL. The strain expressing Cdc10-S contained
sequence encoding LKEE between the C-terminus of Cdc10 and the tag, whereas
Cdc12-S contained the sequence EE (Fig. 6). Strains were constructed by an
assembly PCR-based approach (Johnson and Blobel, 1999). mms21-sp::URA3
contained C200S and H202A mutations and was made by a similar approach.
Alleles of septin genes lacking sumoylation sites have been described (Johnson and
Blobel, 1999). Some strains were cured of 2 m as described previously (Tsalik
and Gartenberg, 1998). Construction details and oligonucleotide sequences are
available on request.
Antibodies and immunoblot analyses
Yeast whole cell lysates were prepared as described by Yaffe and Schatz (Yaffe and
Schatz, 1984) and subjected to SDS-PAGE and immunoblotting followed by
chemiluminescent detection (Supersignal, Pierce) as described previously (Johnson
and Blobel, 1999). Antibodies were, an affinity-purified rabbit polyclonal Ab
against Smt3 (SUMO) (Johnson and Blobel, 1999) and the 16B12 mAb against the
HA epitope (BAbCO). HA and His8-tagged proteins were purified from yeast using
Ni2+-nitriloacetic-acid affinity chromatography under denaturing conditions (6 M
guanidine-HCl) as described by Chen et al. (Chen et al., 2005). Protein assays
(Coomassie Plus, Pierce) were performed so that equal amounts of protein were
added for each lane of a particular experiment.
Fluorescence microscopy
Live yeast cells expressing GFP fusions were imaged using a 63 oil objective on
a Leica DM.RXA microscope with a Cool SNAP fx digital camera (Roper
Scientific) and IP Lab software (Scanlytics, BD Biosciences Bioimaging, Rockville,
MA).
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E. Winter, H. Silver and C. Orr for comments on the manuscript. This
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